查詢結果分析
來源資料
相關文獻
- Cirrhosis Is a Crucial Factor in Mortality and Medical Costs of Acute Respiratory and Renal Failure Patients
- Influential Factors Affecting Prognosis of Snakebite Patients Management: Kaohsiung Chang Gung Memorial Hospital Experience
- Pulmonary Function Changes in Cirrhotic Patients
- Competing Causes of Death in Patients with Oral Cavity Cancer in a Single Cancer Center in Taiwan
- Acute Respiratory Failure Caused by ChylothoraxSecondary to Liver Cirrhosis
- 肝硬化病人之急性腎衰竭
- Age-period-cohort Analysis of Mortality of Chronic Liver Disease and Liver Cirrhosis in Taiwan, 1976~2005
- Comparison of the Outcome of Extremely-Low-Birth-Weight Infants between Two Periods
- 臺灣地區藥物濫用社會成本推估初報
- Recurrent Spontaneous Bacterial Empyema in Cirrhosis: A Case Report
頁籤選單縮合
題 名 | Cirrhosis Is a Crucial Factor in Mortality and Medical Costs of Acute Respiratory and Renal Failure Patients=肝硬化為急性呼吸衰竭及急性腎衰竭病人之死亡率及醫療成本之重要決定因素 |
---|---|
作 者 | 陳碩爵; 張仕妮; 程味兒; 陳志毅; 徐武輝; 林裕超; 邱國梁; 梁信杰; 魏裕峰; 劉炯勳; 宋鴻樟; 施純明; | 書刊名 | 胸腔醫學 |
卷 期 | 27:4 2012.08[民101.08] |
頁 次 | 頁199-208 |
分類號 | 415.534 |
關鍵詞 | 肝硬化; 急性呼吸衰竭; 急性腎衰竭; 死亡率; 醫療成本; Cirrhosis; Acute renal failure; Acute respiratory failure; Mortality; Medical cost; |
語 文 | 英文(English) |
中文摘要 | 背景:在台灣,慢性肝炎和肝硬化病人死亡率很高,尤其是合併急性呼吸衰竭及急性腎衰竭時。本研究利用健保資料庫分析肝硬化是否為急性呼吸衰竭及急性腎衰竭病人死亡率及醫療成本之重要決定因素。方法:從2000年到2007年,我們由健保資料庫找出符合急性呼吸衰竭及急性腎衰竭之病人共13,990位,其中有肝硬化者占2,798位,無肝硬化者11,192位。進一步分析兩組間年齡,性別,合併症,住院天數,醫療成本,出院狀態及在院死亡率之差異,以釐清肝硬化對此類病人之衝擊。結果:無肝硬化之組別雖然有較多之合併症,包括肺炎,敗血症,慢性心肺疾病及糖尿病,但在校正後發現,肝硬化組仍有較高之在院死亡率(OR=2.42, 95% CI=2.17 to 2.70)。肝硬化組出院狀態有較高之死亡及病危自動出院率(83.8%/68.0%, p<0.0001),較短之住院天數(p<0.0001),以及在較年輕及大於三種以上合併症者之族群每日住院花費較高。結論:肝硬化病人合併急性呼吸衰竭及急性腎衰竭時,會造成較高之死亡及病危自動出院率,較短之住院天數但較高之每日住院花費。 |
英文摘要 | Objective: Patients with cirrhosis are at high risk of mortality in Taiwan, especially those with other organ failures. This study focused on determining if cirrhosis is a crucial factor in the mortality and medical costs of acute renal and respiratory failure patients using claims data from the National Health Insurance (NHI) system of Taiwan.Methods: Using the 2000-2007 NHI claims data for patients with acute respiratory and renal failure, we identified 2,798 patients with liver cirrhosis and 11,192 with no cirrhosis diagnosis. These subjects were frequency matched by sex and age, and co-morbidities, length of stay (LOS) in the hospital, cost, discharge status and impact of cirrhosis on in hospital mortality were compared between the 2 groups.Results: Non-cirrhotic patients were more prevalent than patients with the co-morbidities of sepsis, pneumonia, chronic heart/lung disease and diabetes, but the negative impact of cirrhosis on in-hospital mortality was still significant higher after correcting for other factors (OR=2.42, 95% CI=2.17 to 2.70). The cirrhotic patients had higher mortality and against-advice discharge (AAD) rates (83.8%/68.0%, p<0.0001), a shorter LOS (p<0.0001), and a higher daily cost than those with more than 3 co-morbidities and younger age at hospitalization.Conclusion: Patients with acute renal and respiratory failure and a diagnosis of cirrhosis are at an elevated risk of in-hospital mortality, AAD, shorter LOS, and higher daily costs during admission. |
本系統中英文摘要資訊取自各篇刊載內容。